New
HealthMore in Health→
Nature Medicine Issues Expression of Concern on EZH2 Cancer Study
Key Takeaways
- Nature Medicine published an Editorial Expression of Concern dated 18 September 2026 for a paper on SWI/SNF-mutant cancers and EZH2.
- The notice is indexed under DOI 10.1038/s41591-026-04708-9 and does not by itself constitute a retraction or a finding of misconduct.
- The paper's title concerns two central topics in cancer epigenetics: the SWI/SNF chromatin-remodelling complex and the enzyme EZH2.
- An expression of concern signals to readers that a paper's findings should be treated as provisional pending resolution.
DE
DT Editorial Team··via nature.com